Inventor
ASLANIAN ROBERT G
US54 patents
⚠️ This page may combine multiple inventors who share the name “ASLANIAN ROBERT G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
32 patentsUS5696267ADec 9, 1997
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP70 citations95
US6103735AAug 15, 2000
Composition and method for treating allergic diseases
SCHERING CORP35 citations93
US6034251AMar 7, 2000
Phenyl-alkyl-imidazoles
SCHERING CORP38 citations93
US5990147ANov 23, 1999
H3 receptor ligands of the phenyl-alkyl-imidazoles type
SCHERING CORP37 citations93
US5578616ANov 26, 1996
Phenyl-alkyl-imidazoles
SCHERING CORP33 citations93
US7220735B2May 22, 2007
Benzimidazolone histamine H3 antagonists
SCHERING CORP31 citations92
US7105505B2Sep 12, 2006
Benzimidazole derivatives useful as histamine H3 antagonists
SCHERING CORP27 citations92
US6849621B2Feb 1, 2005
Piperidine compounds
SCHERING CORP39 citations92
US6720328B2Apr 13, 2004
Non-imidazole compounds
SCHERING CORP31 citations92
US6100279AAug 8, 2000
Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
SCHERING CORP53 citations92
US5789422AAug 4, 1998
Substituted arylalkylamines as neurokinin antagonists
SCHERING CORP51 citations92
US5840725ANov 24, 1998
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP26 citations91
US7300941B2Nov 27, 2007
Non-imidazole compounds
SCHERING CORP11 citations84
US6951871B2Oct 4, 2005
Indole derivatives useful as histamine H3 antagonists
SCHERING CORP21 citations84
US7638531B2Dec 29, 2009
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
SCHERING CORP19 citations83
US7763623B2Jul 27, 2010
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
SCHERING CORP9 citations82
US7700592B2Apr 20, 2010
α2C adrenoreceptor agonists
SCHERING CORP8 citations82
US6528522B2Mar 4, 2003
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
SCHERING CORP7 citations74
US5945428AAug 31, 1999
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP15 citations74
US6906081B2Jun 14, 2005
Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders
SCHERING CORP11 citations73
US7723342B2May 25, 2010
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
SCHERING CORP4 citations63
US6211182B1Apr 3, 2001
Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
SCHERING CORP3 citations63
US7879880B2Feb 1, 2011
Substituted aniline derivatives useful as histamine H3 antagonists
SCHERING CORP5 citations62
US7737155B2Jun 15, 2010
Nitrogen-containing heterocyclic compounds and methods of use thereof
SCHERING CORP2 citations62
US7635705B2Dec 22, 2009
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SCHERING CORP2 citations62
US7332604B2Feb 19, 2008
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine
SCHERING CORP3 citations62
US7750015B2Jul 6, 2010
Nitrogen-containing heterocyclic compounds and methods of use thereof
SCHERING CORP2 citations61
US7482468B2Jan 27, 2009
Imidazole and benzimidazole derivatives useful as histamine H3 antagonists
SCHERING CORP1 citations52
US7408066B2Aug 5, 2008
Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SCHERING CORP1 citations52
US7238688B2Jul 3, 2007
Piperidine compounds
SCHERING CORP1 citations51
US7531660B2May 12, 2009
1-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereof
SCHERING CORP0 citations48
US6762186B2Jul 13, 2004
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
SCHERING CORP1 citations46
SCHERING PLOUGH CORP
3 patentsUS7884080B2Feb 8, 2011
Azetidinone derivatives and methods of use thereof
SCHERING PLOUGH CORP46 citations93
US7803828B2Sep 28, 2010
Functionally selective alpha2C adrenoreceptor agonists
SCHERING PLOUGH CORP9 citations83
US7846946B2Dec 7, 2010
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SCHERING PLOUGH CORP3 citations62
HUANG XIANHAI
3 patentsMERCK SHARP & DOHME
3 patentsUS8383818B2Feb 26, 2013
Functionally selective alpha2C adrenoreceptor agonists
MERCK SHARP & DOHME5 citations72
US8569312B2Oct 29, 2013
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
US8476274B2Jul 2, 2013
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
MERCK SHARP & DOHME0 citations51
ASLANIAN ROBERT G
2 patentsZHOU GANG
1 patentANTHES JOHN C
1 patentPHARMACOPEIA DRUG DISCOVERY
1 patentZHENG JUNYING
1 patentMCCORMICK KEVIN D
1 patentPALANI ANANDAN
1 patentTING PAULINE C
1 patentShowing the top 50 of 54 patents by PatentIndex Score.